Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Fuji
US Army
Julphar
Covington
Accenture
Moodys
Fish and Richardson
Cerilliant

Generated: October 17, 2017

DrugPatentWatch Database Preview

Insys Dev Co Inc Company Profile

« Back to Dashboard

What is the competitive landscape for INSYS DEV CO INC, and when can generic versions of INSYS DEV CO INC drugs launch?

INSYS DEV CO INC has two approved drugs.

There are ten US patents protecting INSYS DEV CO INC drugs and there have been three Paragraph IV challenges on INSYS DEV CO INC drugs in the past three years.

There are twenty-six patent family members on INSYS DEV CO INC drugs in fifteen countries and ten supplementary protection certificates in four countries.

Summary for Applicant: Insys Dev Co Inc

International Patents:26
US Patents:10
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-001Jan 4, 2012RXYesNo► Subscribe► Subscribe ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-003Jan 4, 2012RXYesYes► Subscribe► Subscribe ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-006Aug 30, 2012RXYesNo► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-005Jan 4, 2012RXYesNo► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-007Aug 30, 2012RXYesNo► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SYNDROS
dronabinol
SOLUTION;ORAL205525-001Mar 23, 2017RXYesYes► Subscribe► SubscribeYY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-003Jan 4, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-003Jan 4, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-006Aug 30, 2012RXYesNo► Subscribe► SubscribeY ► Subscribe
Insys Dev Co Inc
SUBSYS
fentanyl
SPRAY;SUBLINGUAL202788-001Jan 4, 2012RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for INSYS DEV CO INC drugs

Drugname Dosage Strength Tradename Submissiondate
fentanyl
Sublingual Spray0.4 mg/spray
SUBSYS
5/22/2017
dronabinol
Oral Solution5mg/ml
SYNDROS
4/17/2017
dronabinol
Oral solution5 mg/mL
SYNDROS
4/17/2017

International Patent Family for Insys Dev Co Inc Drugs

Country Document Number Estimated Expiration
Denmark1976521► Subscribe
Japan2010535774► Subscribe
Japan2009528272► Subscribe
European Patent Office2184983► Subscribe
Mexico2008009522► Subscribe
Japan5630877► Subscribe
BrazilPI0707235► Subscribe
New Zealand569949► Subscribe
Canada2637672► Subscribe
Russian Federation2008130763► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Insys Dev Co Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00522Netherlands► SubscribePRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006
00523Netherlands► SubscribePRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006
2011000009Germany► SubscribePRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
2014 00016Denmark► SubscribePRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831
2006000022Germany► SubscribePRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126
C/GB06/022United Kingdom► SubscribePRODUCT NAME: FENTANYL HYDROCHLORIDE; REGISTERED: UK EU/1/05/326/001 20060124
2014000024Germany► SubscribePRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
00653Netherlands► SubscribePRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906
0653Netherlands► SubscribePRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906
00521Netherlands► SubscribePRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Cerilliant
Julphar
Express Scripts
Baxter
Medtronic
Federal Trade Commission
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot